CFC-Containing Albuterol Inhalers To Be Removed By 2009
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's final rule sets a deadline one year earlier than the latest possible date suggested in the proposed rule. Manufacturers have said that once a phase-out date was set they could build sufficient supply of ozone-friendly albuterol product within 18 months.
You may also be interested in...
The History Behind The Drug-Device Combos Targeted By FTC
Of the 16 products whose Orange Book patent listings have been challenged by the FTC, six have no generic competitors and two faced first generic launches this year. A review of their patent and pricing battles shows the difficulties in developing generics for these complex drugs.
The History Behind The Drug-Device Combos Targeted By FTC
Of the 16 products whose Orange Book patent listings have been challenged by the FTC, six have no generic competitors and two faced first generic launches this year. A review of their patent and pricing battles shows the difficulties in developing generics for these complex drugs.
Teva Taps UCB’s Respiratory Expertise To Promote ProAir HFA In The U.S.
Deal comes as Teva seeks to capture remaining market share from CFC-containing albuterol products, which must be discontinued by year-end, firm tells "The Pink Sheet" DAILY.